Anti-Phospholipid Screen IgG/IgM

The Anti-Phospholipid Screen IgG/IgM assay is an enzyme immunoassay (EIA) intended to detect the presence of IgG and IgM class autoantibodies against cardiolipin, phosphatidyl serine, phosphatidyl inositol, phosphatidic acid and β2-Glycoprotein I in human serum or plasma.


Catalog No Size
Product Catalog No: EIA-3591 Pack Size: 96 Wells

Pack Size:
Pack Size:
Pack Size:
Pack Size:

Category:
Test Principle

A mixture of highly purified cardiolipin, phosphatidyl serine, phosphatidyl inositol, phosphatidic acid and human β2-glycoprotein I is bound to microwells. Antibodies against these antigens, if present in diluted serum or plasma, bind to the respective antigens. Washing of the microwells removes unspecific serum and plasma components. Horseradish peroxidase (HRP) conjugated anti-human IgG or IgM immunologically detects the bound antibodies forming a conjugate/antibody/antigen complex. Washing of the microwells removes unbound conjugate. An enzyme substrate in the presence of bound conjugate hydrolyzes to form a blue colour. The addition of an acid stops the reaction forming a yellow end-product. The intensity of this yellow colour is measured photometrically at 450 nm.

Order Enquiry

Order Enquiry Form

References
  • Hughes, G.R.V., Harris, E.N. and Gharavi, A.E. The Anticardiolipin Syndrome. J. Rheumatol. 1986; 13, 3: 486 – 489.
  • Harris, E.N. et al. Evaluation of the anti-cardiolipin antibody test: report of an international Workshop held 4 April 1986. Clin. Exp. Immunol. 1987; 68: 215 – 222.
  • Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RHWM, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
  • Domke, N. and Siegert, G. Phospholipidantikörper und ihre klinische Bedeutung. Zeitschrift für Klinische Medizin 1988; Heft 16: 1399 – 1401.
  • Pengo, V. et al. Immunological Specificity and Mechanism of Action of IgG Lupus Anticoagulants. Blood 1987; Vol. 70, No 1: 69 – 76.
  • Triplett, D.A. Coagulation Assays for the Lupus Anticoagulant: Review and Critique of Current Methodology. Stroke 1992; Vol. 23, No 2 [suppl I]: I-11 – I-14.
  • Harris, E.N. Serological Detection of Antiphospholipid Antibodies. Stroke 1992; Vol. 23, No 2 [suppl I]: I-3 – I-6.
  • Eilat, D. et al. Evaluation of cross-reaction between anti-DNA and anti-cardiolipin antibodies in SLE and experimental animals. Clin. Exp. Immunol. 1986; 65: 269 – 278.
  • Matsuda, J. et al. Detection of Beta-2-Glycoprotein-I-dependend Antiphospholipid Antibodies and Antibeta- 2-Glycoprotein-I Antibody in Patients with Systemic Lupus Erythematosus and in Patients with Syphilis. Int. Arch. Allergy Immunol. 1994; 103: 239 – 244.
  • Kalunian, K.C. et al. Clinical Significante of a Single Test for Anti-Cardiolipin Antibodies in Patients with Systemic Lupus Erythematosus. Am. J. Med. 1988; Vol. 85: 602 – 608.
  • Al-Momen, A.-K. et al. IgA Antiphospholipid and Adrenal Insufficieny: Is there a link ? Thromb. Res. 1991; Vol. 64, No 5: 571 – 578.
Enquiry